Disclosure Of Entity's Operating Segments [Text Block]

Embla Medical hf - Filing #5889952

Concept	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	As at 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2023-01-01 to 2023-12-31	As at 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31
Disclosure of entity's operating segments [text block]	—	4. Segment information	—	—	—	—	—	—	—	—
Disclosure of operating segments [text block]	—	—	—	—	—	—	—	—	—	—
Disclosure of operating segments [abstract]
Disclosure of operating segments [line items]
Revenue	—	854,889,000 USD	—	—	—	785,683,000 USD	—	—	—	—
Tax expense (income)	—	21,603,000 USD	—	—	—	17,206,000 USD	—	—	—	—
Profit (loss) before tax	—	90,563,000 USD	—	—	—	76,007,000 USD	—	—	—	—
Profit (loss)	682,000 USD	68,960,000 USD	—	68,278,000 USD	68,278,000 USD	58,801,000 USD	—	412,000 USD	58,389,000 USD	58,389,000 USD
Assets	—	—	1,538,965,000 USD	—	—	—	1,385,682,000 USD	—	—	—
Liabilities	—	—	758,266,000 USD	—	—	—	680,676,000 USD	—	—	—
Cash flows from (used in) operating activities	—	116,066,000 USD	—	—	—	94,324,000 USD	—	—	—	—
Cash flows from (used in) investing activities	—	104,770,000 USD	—	—	—	57,147,000 USD	—	—	—	—
Cash flows from (used in) financing activities	—	5,761,000 USD	—	—	—	40,959,000 USD	—	—	—	—
Disclosure of products and services [text block]	—	—	—	—	—	—	—	—	—	—
Disclosure of products and services [abstract]
Disclosure of products and services [line items]
Disclosure of geographical areas [text block]	—	—	—	—	—	—	—	—	—	—
Disclosure of geographical areas [abstract]
Disclosure of geographical areas [line items]
Disclosure of major customers [text block]	—	—	—	—	—	—	—	—	—	—
Disclosure of major customers [abstract]
Disclosure of major customers [line items]